IFRX
IFRX
NASDAQ · Biotechnology

Inflarx Nv

Penny Stocks Biotech Stocks Healthcare Stocks
$2.01
+0.00 (+0.00%)
As of Aug 15, 2:22 AM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 11 79%
Hold 3 21%
Sell 0 0%
Price Target
Analyst Price Target +198.5% upside
Low Target $4.29
Average Target $6.00
High Target $7.91
Current Price $2.01
Current
$2.01
Target
$6.00
$4.29 $6.00 avg $7.91
Scenario Analysis
Bear Case
$4.29
113.4%
Low target
Base Case
$6.00
+198.5%
Avg target
Bull Case
$7.91
+293.5%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$2.95
-31.8% from high
52-Week Low
$0.78
+158.0% from low
Target vs 52W High
$6.00
+103.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.4%